A detailed history of Virtu Financial LLC transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Virtu Financial LLC holds 50,537 shares of XFOR stock, worth $17,182. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,537
Holding current value
$17,182
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$0.58 - $1.47 $29,311 - $74,289
50,537 New
50,537 $29,000
Q4 2023

Feb 26, 2024

BUY
$0.61 - $0.99 $77,907 - $126,440
127,718 New
127,718 $107,000
Q2 2023

Jul 27, 2023

SELL
$0.82 - $2.49 $80,697 - $245,045
-98,412 Reduced 86.72%
15,077 $29,000
Q1 2023

May 01, 2023

BUY
$0.8 - $1.22 $90,791 - $138,456
113,489 New
113,489 $99,000
Q2 2022

Aug 09, 2022

SELL
$0.88 - $1.91 $4,910 - $10,657
-5,580 Reduced 21.49%
20,385 $20,000
Q1 2022

May 17, 2022

BUY
$1.48 - $2.58 $38,428 - $66,989
25,965 New
25,965 $45,000

Others Institutions Holding XFOR

About X4 Pharmaceuticals, Inc


  • Ticker XFOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,646,096
  • Market Cap $23.3M
  • Description
  • X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...
More about XFOR
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.